Prati
Victor C. Kok, MD, MMSc, PhD, FACP, HICR(HMS)
Victor C. Kok, MD, MMSc, PhD, FACP, HICR(HMS)
Kuang Tien General Hospital Cancer Center
Potvrđena adresa e-pošte na alumni.harvard.edu
Naslov
Citirano
Citirano
Godina
Cancer-derived exosomes: their role in cancer biology and biomarker development
VC Kok, CC Yu
International Journal of Nanomedicine, 8019-8036, 2020
3422020
The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study
VC Kok, HJ Tsai, CF Su, CK Lee
International Journal of Gynecological Cancer 25 (6), 968-976, 2015
1532015
Current understanding of the mechanisms underlying immune evasion from PD-1/PD-L1 immune checkpoint blockade in head and neck cancer
VC Kok
Frontiers in oncology 10, 268, 2020
1012020
Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study
VC Kok, JT Horng, WS Chang, YF Hong, TH Chang
PloS one 9 (6), e99102, 2014
922014
Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma
HM Wang, YW Huang, JS Huang, CH Wang, VC Kok, CM Hung, ...
Annals of surgical oncology 14, 3011-3018, 2007
772007
Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study
CW Chang, VC Kok, TC Tseng, JT Horng, CE Liu
Plos one 7 (12), e50729, 2012
482012
Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis
VC Kok, JT Horng, JL Huang, KW Yeh, JJ Gau, CW Chang, LZ Zhuang
BMC cancer 14, 1-10, 2014
472014
Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
YC Chen, VC Kok, CH Chien, JT Horng, JJP Tsai
Therapeutics and clinical risk management, 1315-1323, 2015
462015
Diagnostic value of serum procalcitonin, lactate, and high-sensitivity C-reactive protein for predicting bacteremia in adult patients in the emergency department
CT Lin, JJ Lu, YC Chen, VC Kok, JT Horng
PeerJ 5, e4094, 2017
412017
Compassionate extubation for a peaceful death in the setting of a community hospital: a case-series study
VC Kok
Clinical interventions in aging, 679-685, 2015
412015
Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in Taiwan
VC Kok, JT Horng, HL Lin, YC Chen, YJ Chen, KF Cheng
BMC cardiovascular disorders 12, 1-9, 2012
402012
Sorafenib with transarterial chemoembolization achieves improved survival vs. sorafenib alone in advanced hepatocellular carcinoma: a nationwide population-based cohort study
VC Kok, YC Chen, YY Chen, YC Su, MC Ku, JT Kuo, GJ Yoshida
Cancers 11 (7), 985, 2019
392019
The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics
E Cash, S Sephton, C Woolley, AM Elbehi, A RI, B Ekine-Afolabi, VC Kok
Journal of Experimental & Clinical Cancer Research 40, 1-14, 2021
372021
Positive association between hypertension and urinary bladder cancer: epidemiologic evidence involving 79,236 propensity score-matched individuals
VC Kok, HW Zhang, CT Lin, SC Huang, MF Wu
Upsala journal of medical sciences 123 (2), 109-115, 2018
372018
Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals
VC Kok, JT Horng, MN Wang, ZY Chen, JT Kuo, GD Hung
Osteoporosis International 29, 973-985, 2018
362018
Risk of autoimmune disease in adults with chronic insomnia requiring sleep-inducing pills: a population-based longitudinal study
VC Kok, JT Horng, GD Hung, JL Xu, TW Hung, YC Chen, CL Chen
Journal of general internal medicine 31, 1019-1026, 2016
312016
Late-onset epilepsy and subsequent increased risk of dementia
ZR Tsai, HW Zhang, CH Tseng, HC Peng, VC Kok, GP Li, CA Hsiung, ...
Aging (Albany NY) 13 (3), 3573, 2021
292021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+ capecitabine (N+ C) vs lapatinib+ capecitabine (L+ C …
MS Dai, YH Feng, SW Chen, N Masuda, T Yau, ST Chen, YS Lu, YS Yap, ...
Breast Cancer Research and Treatment 189, 665-676, 2021
232021
Incidence of retinal vein occlusion with long-term exposure to ambient air pollution
HW Zhang, CW Lin, VC Kok, CH Tseng, YP Lin, TC Li, FC Sung, CP Wen, ...
PLoS One 14 (9), e0222895, 2019
212019
Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells
CH Huang, JS Ciou, ST Chen, VC Kok, Y Chung, JJP Tsai, ...
PeerJ 4, e2478, 2016
202016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20